Triursus Therapeutics is Biotechnology in United States that focus on Crohn disease business. Founded in 2016. They cover business area such as operator, novel monoclonal, several target, serious inflammatory disease, inflammatory bowel disease, Crohn disease, ulcerative colitis, host, GVHD, patient, morbidity, mortality.
2016
( 10 years old in 2026 )
Crohn Disease
-
Palo Alto, CA
United States
Private
operatornovel monoclonalseveral targetserious inflammatory diseaseinflammatory bowel diseaseCrohn diseaseulcerative colitishostGVHDpatientmorbiditymortality
* We use standard office opening hours in near Triursus Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Triursus Therapeutics is Biotechnology business from United States that founded in 2016 (10 years old in 2026), Triursus Therapeutics business is focusing on Crohn Disease.
Triursus Therapeutics headquarter office and corporate office address is located in Palo Alto, CA United States.
Triursus Therapeutics was founded in United States.
In 2026, Triursus Therapeutics is currently focus on Crohn disease sector.
Above is snippet of Google Trends for "Crohn disease" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Triursus Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
